U.S. Markets closed

Aida Pharmaceuticals, Inc. (AIDA)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.01850.00 (0.00%)
At close: 10:09AM EDT
People also watch

Aida Pharmaceuticals, Inc.

31 Dingjiang Road
Jianggan District
Hangzhou 310016
86 571 8580 2712

Full Time Employees450

Key Executives

Mr. Biao JinChairman and Chief Exec. Officer19.06kN/A69
Ms. Lin HuiChief Financial Officer and Principal Accounting Officer12.7kN/A51
Mr. Yuejun JiangChief of Investment Department and Sec.N/AN/A42
Amounts are as of December 31, 2007 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Aida Pharmaceuticals, Inc., together with its subsidiaries, develops, produces, and distributes antibiotics, cardiovascular, and anti cancer drugs in China. It offers products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet, and ointment. The company provides Etimicin Sulfate, an injectable powder form, as well as rh-Apo2l, a biopharmaceutical therapy for cancers. Aida Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Hangzhou, China.

Corporate Governance

Aida Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.